The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species production

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Bcl-xL is a key regulator of apoptosis and is implicated in vertebrate development.
• Beyond apoptosis, Bcl-xL influences cell migration and mitochondrial metabolism, potentially promoting cancer metastasis.
• The precise molecular mechanisms linking Bcl-xL to cell migration, particularly in breast cancer, require further elucidation.

Purpose of the Study:

• To investigate the role of Bcl-xL in controlling cell migration in breast cancer cells.
• To identify the specific cellular compartments and molecular interactions of Bcl-xL involved in regulating cell migration.

Main Methods:

• Silencing of Bcl-xL in Hs578T and MDA-MB231 breast cancer cell lines.
• Re-expression of Bcl-xL targeted to mitochondria or endoplasmic reticulum.
• Treatment with BH3 mimetics (ABT-737, WEHI-539) and a BH4 peptide disrupting the Bcl-xL/VDAC1 complex.

Main Results:

• Bcl-xL silencing significantly impaired breast cancer cell migration.
• Mitochondrial-localized Bcl-xL, but not ER-localized Bcl-xL, rescued migration defects.
• The pro-migratory effect of Bcl-xL was independent of Bax and BH3-only proteins but dependent on interaction with VDAC1.
• Disruption of the Bcl-xL/VDAC1 complex inhibited migration, suggesting Bcl-xL regulates VDAC1 permeability to modulate reactive oxygen species production.

Conclusions:

• Bcl-xL plays a critical role in breast cancer cell migration, mediated through its interaction with VDAC1 at the mitochondria.
• This interaction influences mitochondrial metabolism and reactive oxygen species production, thereby promoting cell migration.
• The VDAC1/Bcl-xL complex represents a potential therapeutic target for inhibiting metastasis in breast cancer.